Qvr LLC Bristol Myers Squibb CO Call Options Transaction History

Qvr LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $2.55 Million - $3.02 Million	-37,300 Reduced 89.88%	4,200 $302,000
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $1,599 - $945,132	12,300 Added 42.12%	41,500 $2.95 Million
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $3.49 Million - $3.85 Million	-48,100 Reduced 62.23%	29,200 $2.25 Million
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $4.75 Million - $5.7 Million	77,300 New	77,300 $5.65 Million
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $1.38 Million - $1.61 Million	-25,700 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $384,605 - $450,515	6,500 Added 33.85%	25,700 $1.52 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $1.02 Million - $1.11 Million	16,400 Added 585.71%	19,200 $1.28 Million
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $41,538 - $46,718	700 Added 33.33%	2,800 $177,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $121,254 - $137,403	2,100 New	2,100 $129,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.